Navigation Links
SHPS Receives Re-Accreditation from URAC for Multiple Health Management Programs
Date:6/10/2009

LOUISVILLE, Ky., June 10 /PRNewswire/ -- SHPS announced today that it has earned re-accreditation for five of its Carewise Health programs from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry. The five programs to receive URAC re-accreditation are: case management, disease management, utilization management, workers' compensation utilization management, and health call center.

"SHPS is proud to receive re-accreditation from URAC for these five programs," said Rishabh Mehrotra, president and CEO of SHPS. "URAC accreditation is critical to the success of our Carewise Health programs. It illustrates our ability to provide high-quality health management services to our customers."

Carewise Health specializes in employee health solutions. By combining multiple health management services into one holistic program, Carewise Health is able to co-manage all of the lifestyle and clinical issues that affect a person's health. This unique approach improves personal health and reduces employer healthcare costs.

"SHPS should be commended for meeting strict quality standards," said Alan P. Spielman, URAC president and CEO. "It is critically important for healthcare organizations to make a commitment to quality and accountability. URAC accreditation is a demonstration of that commitment."

URAC has a modular approach to accreditation which allows for a diverse range of healthcare organizations to apply for URAC accreditation with the flexibility to achieve accreditation for a wide spectrum of managed care services. This approach adapts to the continuing evolution of the healthcare system. Each module is a set of standards established for a particular healthcare function.

About URAC

URAC, an independent, nonprofit organization, is a leader in promoting healthcare quality through accreditation and certification programs. URAC's standards keep pace with the rapid changes in the healthcare system, and provide a mark of distinction for healthcare organizations to demonstrate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in setting meaningful standards for the healthcare industry. For more information, visit www.urac.org.

About SHPS | Carewise Health

Carewise Health is marketed by SHPS, Inc. SHPS is a leading provider of health management and benefits administration services, serving employers, government agencies, health plans, and third-party administrators through the company's Carewise(R) Health, Landacorp, and SHPS brands. SHPS has a total of eight URAC accreditations including: case management, disease management, utilization management, workers' compensation utilization management, health call center (nurse line), consumer education and support, HIPAA privacy, and comprehensive wellness. Visit www.carewisehealth.com for more information.


'/>"/>
SOURCE SHPS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Herley Receives a $1.2 Million Contract Award for Complex Integrated Microwave Assemblies for U.S. Electronic Attack Aircraft
2. Elder Care Expert Doctor Marion Receives Accolades from Lehman College, Mature Market Resource Center in Same Week
3. Medifocus, Inc. receives Authorization Approval from Health Canada to launch its pivotal Phase III clinical study of focused microwave heating for treatment of breast cancer in Canada
4. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
5. MedApps Receives FDA Clearance on a New Way to Bring Cost-Effective Remote Health Monitoring to More People
6. Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
7. Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device
8. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
9. XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration
10. Cepheid Receives Health Canada License for Xpert(R) HemosIL(R) FII & FV Test
11. Innovia Receives FDA Clearance For The InnoPort(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: